Ann: FDA allows Veyonda Pre-IND Submission for COVID-19, page-15

Harvett......

Sentiment: NONE
Disclosure: NOT HELD.
Post: As usual, poorly written with no attempt to read it before posting.

Its unlikely to surprise anyone that I disagree with your “position” if you can call it that.

1. This IND application is VERY significant news... and I’ll bet you it will be granted.

Further... because of the current pandemic it will be given every opportunity to fly through the process... not least because the patients in intensive care to whom it will be aimed .... will provide the data being sought in a relatively very short space of time.

2. This company is laser sharp in knowing the direction in which it’s heading. No “all over the shop” at all.

3. This present Covid-19 opportunity has appeared because of an investigation into the detailed way that Veyonda is acting that was put in train a year ago. Significant new findings now confirmed... absolutely had to be followed up. See a further opportunity... and run with it swiftly and with conviction.

4. Secured an underwritten Entitlement fund raising from existing shareholders of record.... and has done so for a significant amount with which to further fund the very promising opportunities. Sorry if you have missed out on this.

5. I only wish a certain other company that both I and you DO hold shares in, could have managed that recent Cap raise with such aplomb. Ah well..... two different horses with two different jockeys I guess. The difference between us though is that.... I sincerely hope they BOTH do extremely well.

Apples